ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
The Mitochondrial Metabolism Gene ECH1 Was Identified as a Novel Biomarker for Diabetic Nephropathy: Using Bioinformatics Analysis and Experimental Confirmation.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High glucose-induced PLCG1 histone acetylation to promote ferroptosis by LAMP2A/HSPA8 in a diabetic nephropathy model.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic nephropathy (DN) is a major cause of kidney failure, and its incidence is increasing worldwide. Existing studies have shown that mitochondrial dysfunction is potentially related to the pathogenesis of DN. This study aims to explore novel biomarkers related to mitochondrial metabolism that may affect the diagnosis and treatment of DN. Methods: The Gene Expression Omnibus (GEO) database and MitoCarta3.0 database were used to download the DN datasets and mitochondrial metabolism-related genes (MRGs), respectively. Differentially expressed genes (DEGs) were identified using the "limma" R package, and their functional analysis was performed through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Important gene modules were identified by weighted gene Coexpression network analysis (WGCNA) clustering. Next, we obtained key genes by intersecting DEGs, important gene modules and MRGs. The ROC curve was employed to assess the sensitivity and specificity of the diagnostic indicators for DN. Finally, the expression of key genes was assessed in the in vitro DN model and the mechanisms of key gene were investigated. Results: A total of 343 DEGs were identified, with functional analysis revealing a primary focus on metabolic biological processes. A sum of 752 important module genes was ascertained. PDK4, ECH1, and ETFB were selected as key genes. Then, the expression level and specificity of key genes were verified by the GSE104954 dataset, which confirmed the high diagnostic value of PDK4 and ECH1 (AUC>0.9). Finally, the q-PCR, flow cytometry, and Western blot results indicated that key genes were significantly decreased in high glucose induced HK-2 cells. ECH1 could promote fatty acid oxidation and inhibit cell apoptosis, oxidative stress, and inflammation. Conclusion: This study identified biomarkers related to mitochondrial metabolism in DN, providing new insights and directions for the diagnosis and treatment of DN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.